glp-1 tablet for weight loss Drugs from the Gray Market Novo Nordisk launches its Wegovy

Nevertheless, the smaller sample sizes limit the statistical power to detect a relatively uncommon event like retinopathy worsening

While most of our sample (60.6%) indicate they have never used a GLP-1 medication, 12.0% said they are currently using a GLP-1 medication, and 7.9% said they utilized a GLP-1 drug previously

It involves more than just diet and exercise

The evidence is mostly clinical observation and patient-reported outcomes

Crucially, GLP-1 directly influences appetite regulation by interacting with specific receptors in your brain involved in hunger and satiety

Cagrilintide is the most evidence-anchored option because CagriSema shows that adding amylin to a GLP-1 backbone improves outcomes